9 employees
Saliva based next generation prognostics solution for early stage detection of multiple cancers in a non invasive and painless manner.
2019
$200K
from 1 investors over 1 rounds
CURO BIOSCIENCES PRIVATE LIMITED raised $200K on October 1, 2021
Investors: LetsVenture